Veeva price target lowered to $170 from $185 at Canaccord

Canaccord analyst David Hynes lowered the firm’s price target on Veeva to $170 from $185 and keeps a Hold rating on the shares. The analyst said they reported typically solid, upside Q4 results as seasonally strong billings should translate to strong cash generation in Q1.